Skip to main content
SpringerLink
Log in

Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests

  • Research Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

The aim of the present work was to investigate the role of ondansetron on the high fat diet (HFD) induced obese mice for behavioral and biochemical alterations using chronic unpredictable mild stress (CUMS) model of depression. Animals were fed with high fat diet for 14 weeks and subjected to different stress procedures for 4 weeks. Treatment with ondansetron was started on day 15. After day 28 behavioral assays and biochemical estimations were performed. Behavioral paradigms viz. sucrose preference test, locomotor score, forced swim test (FST) and elevated plus maze (EPM), whereas biochemical parameters like plasma glucose, total cholesterol, triglycerides and total proteins were estimated. Results examines that in behavioral assays, ondansetron significantly (P < 0.05) increased sucrose consumption, reduced immobility time in FST, increased the percent entries and time in open arm in EPM. In biochemical assessments elevated plasma glucose, total cholesterol, triglycerides and total proteins were significantly (P < 0.05) reversed by ondansetron treatment in HFD obese animals subjected to CUMS. The study indicates that the obese mice subjected to CUMS exhibited severe depressive-like symptoms and ondansetron significantly reversed the behavioral and biochemical alterations. In the present study the plasma glucose level indicates that, it could be “altered glucose level” playing an important role in depression co-morbid with obesity. Ondansetron through allosteric modulation of serotonergic system elevates the serotonin level and thereby regulates the insulin secretion and hence, reversing the “altered glucose level”, could be the possible antidepressive-like mechanism against depression co-morbid with obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Adeyemi OO, Yemitan OK, Taiwo AE (2006) Neurosedative and muscle-relaxant activities of ethyl acetate extract of Baphnia nitidia AFZEL. J Ethnopharmacol 106:312–316

    Article  PubMed  Google Scholar 

  • Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L (2009) Obesity and metabolic syndrome increases the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 17:889–898

    Article  PubMed  Google Scholar 

  • Barry JA, Kuczmierczyk AR, Hardiman PJ (2009) Anxiety and depression in polysystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 26:2442–2451

    Article  Google Scholar 

  • Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res 287:173–196

    Article  CAS  PubMed  Google Scholar 

  • Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA (2008) Chronic unpredictable stress induces a cognitive deficit and anxiety like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacol 33:320–331

    Article  CAS  Google Scholar 

  • Bruder-Nascimento T, Campos DHS, Alves C, Thomaz S, Cicogna AC, Cordellini S (2013) Effect of chronic stress and high fat diet on metabolic and nutritional parameters in Wistar rats. Arq Bras Endocrinol Metab 57:642–649

    Article  Google Scholar 

  • Buccolo G, David H (1973) Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19:476–482

    Google Scholar 

  • Carvalho F, Barros D, Silva J, Rezende E, Soares M, Fregoneze J, De Castro-E-Silva E (2005) Hyperglycemia induced by pharmacological activation of central serotonergic pathways depends on the functional integrity of brain CRH system and 5–HT3 receptors. Horm Metab Res 3:482–488

    Article  Google Scholar 

  • Cryan JF, Holmes A (2005) The ascent of mouse: advances in modeling human depression and anxiety. Nat Rev Drug Discov 4:775–790

    Article  CAS  PubMed  Google Scholar 

  • Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238–245

    Article  CAS  PubMed  Google Scholar 

  • Davies PA, Pistis M, Hanna MC, Peters JA, Lambrts JJ, Hales TG, Kirkness JF (1999) The 5-HT3B subunit is a major determinant of serotonin receptor function. Nature 397:359–363

    Article  CAS  PubMed  Google Scholar 

  • Der-Avakian A, Markou A (2002) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:68–77

    Article  Google Scholar 

  • Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacol (Berlin) 121:66–72

    Article  CAS  Google Scholar 

  • Dong C, Sanchez LE, Price RA (2004) Relationship of obesity to depression: a family-based study. Int J Obes Relat Metab Disord 28:790–795

    Article  CAS  PubMed  Google Scholar 

  • Dubin AE, Huvar R, D’Andrea MR, Pyati J, Zhu JY, Joy KC, Wilson SJ, Galindo JE, Glass CA, Luo L, Jackson MR, Lovenberg TW, Erlander MG (1999) The pharmacological and functional characteristics of the serotonin 5-HT3 receptor are specifically modified by a 5-HT3B receptor subunit. J Biol Chem 274:30799–30810

    Article  CAS  PubMed  Google Scholar 

  • Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, Bondy B, Parsons C, Gilling K, Zieglgansberger W, Holsboer F, Rupprecht R (2003) Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatr 8:994–1007

    Article  CAS  Google Scholar 

  • Engeland CG, Martin K, Klaus-Peter O (2003) Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats. Pharmacol Biochem Behav 74:433–447

    Article  CAS  PubMed  Google Scholar 

  • Epel E, Jimenez S, Brownell K, Stroud L, Stoney C, Niaura R (2004) Are stress eaters at risk for the metabolic syndrome? Ann NY Acad Sci 1032:208–210

    Article  PubMed  Google Scholar 

  • Evans JL, Goldfine ID, Maddux BA, Grodsky GM (2003) Are oxidative stress activated signaling pathways mediators of insulin resistance and cell dysfunction? Diabetes 52:1–8

    Article  CAS  PubMed  Google Scholar 

  • Everson-Rose SA, Meyer PM, Powell LH, Pandey D, Torrens JI, Kravitz HM, Bromberger JT, Matthews KA (2004) Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27:2856–2856

    Article  PubMed  Google Scholar 

  • Faerber L, Drechsler S, Ladenburger S, Gschaidmeier WH (2007) Fischer W (2007) The neuronal 5-HT3 receptor network after 20 years of research-Evolving concepts in management of pain and inflammation. Eur J Pharmacol 560:1–8

    Article  CAS  PubMed  Google Scholar 

  • Garcia-Bueno B, Perez-Neivas BG, Leza JC (2010) Is there a role for nuclear receptor PPAR gamma in neuropsychiatric diseases? Int J Neuropsychopharmacol 13:1411–1429

    Article  CAS  PubMed  Google Scholar 

  • Garza JC, Guo M, Zhang W, Lu XY (2012) Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3beta/beta-catenin signaling. Mol Psychiatry 17:790–808

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Greenshaw AJ, Silverstone H (1997) The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Drugs 53:20–39

    Article  CAS  PubMed  Google Scholar 

  • Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meetsneuropsycho- pharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacol 37:137–162

    Article  CAS  Google Scholar 

  • Heimes K, Feistel B, Verspohl EJ (2009) Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts. Eur J Pharmacol 624:58–65

    Article  CAS  PubMed  Google Scholar 

  • Herrstedt J, Dombernowsky P (2007) Anti-emetic therapy in cancer chemotherapy: Current status. Basic Clin Pharmacol Toxicol 101:143–150

    Article  CAS  PubMed  Google Scholar 

  • Hogg S (1996) A review of the validity and variability of the elevated plus maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21–30

    Article  CAS  PubMed  Google Scholar 

  • Horacek J, Kuzmiakova M, Hoschl C, Andel M, Bahbonh R (1999) The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology 24:785–797

    Article  CAS  PubMed  Google Scholar 

  • Isingrini E, Camus V, Guisquet AM, Pingaud M, Devers S, Belzung C (2010) procedures with a high fat diet: a model of fluoxietine resistance in mice. Plos one 5:e10404

  • Jellinger PS (2007) Metabolic consequence of hyperglycemia and insulin resistance. Clin Cornerstone 8:S30–S42

    Article  PubMed  Google Scholar 

  • Koller A (1948) Total serum protein. In: Kaplan LA, Pesce AJ (eds) Clin Chem, theory, analysis, and correlation. St Louis, Mosby Company p, pp 1316–1319

    Google Scholar 

  • Levine AS, Morley JE (1981) Stress-induced eating in rats. Am J Physiol 241:R72–R76

    CAS  PubMed  Google Scholar 

  • Marfella R, Verrazzo G, Acampora R, La Marca C, Giunta R, Lucarelli C, Paolisso G, Ceriello A, Giugliano D (1995) Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol 268:E1167–E1173

    CAS  PubMed  Google Scholar 

  • Meittini F, Prencipe F, Bardelli G, Giannini G, Tarli P (1978) The 4-hydroxybenzoate/4-aminophenazone. Chromogenic Syst Clin Chem 24:2161–2165

    Google Scholar 

  • Moore MC, Geho WB, Lautz M, Farmer B, Neal DW, Cherrington AD (2004b) Portal serotonin infusion and glucose disposal in conscious dogs. Diabetes 53:14–20

    Article  CAS  Google Scholar 

  • Moore MC, Kimura K, Shibata H, Honjoh T, Saito M, Everett CA, Smith MS (2005b) Cherrington AD (2005b) Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs. Am J Physiol Endocrinol Metab 289:E225–E231

    Article  CAS  Google Scholar 

  • Pan A, Ye X, Franco OH, Li H, Yu Z, Zou S, Zhang Z, Jiao S, Lin X (2008) Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord 109:75–82

    Article  CAS  PubMed  Google Scholar 

  • Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, Skelin M, Jevsek M, Fink H, Rupnik M, Walter DJ (2009) Intracellular serotonin modulates insulin secretion from pancreatic β-cells by protein serotonylation. PLoS Biol 7:e1000229

    Article  PubMed Central  PubMed  Google Scholar 

  • Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336

    CAS  PubMed  Google Scholar 

  • Qing-Qiu M, Siu-Po I, Kam-Ming K, Sam-Hip T, Chun-Tao C (2009) Peony glycosides produce antidepressant-like action in mice exposed to chronic unpredictable mild stress: Effects on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor. Prog Neuropsychopharmacol Biol 33:1211–1216

    Google Scholar 

  • Quon MJ (2001) Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 86:4615–4617

    Article  CAS  PubMed  Google Scholar 

  • Ramamoorthy R, Radhakrishnan M (2010) The auspicious role of 5-HT3 receptors in depression: A probable neuronal target. J Psychopharmacol 24:455–469

    Article  Google Scholar 

  • Ramamoorthy R, Radhakrishnan M, Borah M (2008) Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models. Behav Pharmacol 19:29–40

    Article  CAS  PubMed  Google Scholar 

  • Rosgan NL, Carter MS, Elman S, Bauer M, Love M, Korenman SG (2002) Common treatment of polysystic ovary syndrome and major depressive disorder: case study and review. Curr Drug Targets Immune Endocr Metabol Disord 2:91–102

    Google Scholar 

  • Ruddell RG, Mann DA, Ramm GA (2008) The function of serotonin within the liver. J Hepatol 48:666–675

    Article  CAS  PubMed  Google Scholar 

  • Sharma S, Fulton S (2012) Diet-induced obesity promotes depressive-like behavior that is associated with neural adaptations in brain reward circuitry. Int J Obes 37:382–389

    Article  Google Scholar 

  • Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P (2005) Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 52:313–320

    Article  CAS  PubMed  Google Scholar 

  • Talior I, Yarkoni M, Bashan N, Eldar-Fielman H (2003) Increased glucose uptake promotes oxidative stress and PKC delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol 285:E295–E302

    CAS  Google Scholar 

  • Tecott LH, Maricq AV, Julius D (1993) Nervous system distribution of the 5-HT3 receptor in rat brain using radioligand binding. Proc Natl Acad Sci U S A 90:1430–1434

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Trinder P (1969) Enzymatic method of glucose estimation. Ann Clin Biochem 6:24–33

    Article  CAS  Google Scholar 

  • Wagner SC, Daniel DS, Monica MM, Mauro S (2012) Serotonin modulates hepatic 6-phosphofructo-1-kinase in an insulin synergistic Manner. Int J Biochem Cell Biol 44:150–157

    Article  Google Scholar 

  • Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS. Neuropsychobiol 52:90–110

    Article  CAS  Google Scholar 

  • Wu LM, Han H, Wang QN, Hou HL, Tong H, Yan XB, Zhou JN (2007) Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacol 32:2500–2510

    Article  CAS  Google Scholar 

  • Xue R, Jin ZL, Chen HX, Yuana L, He XH, Zhang YP (2013) Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor. Eur J Neuropsychopharmacol 23:728–741

    Article  CAS  Google Scholar 

  • Yamada N, Katsuura G, Ochi Y, Ebihara K, Kusakabe T, Hosoda K, Nakao K (2011) Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152:2634–2643

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We are thankful to Birla Institute of Technology and Science (BITS), Pilani, India for providing support and research facilities to pursue this work.

Conflict of interest

All authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pharmacy, Birla Institute of Technology & Science, Pilani, Rajasthan, 333031, India

    Yeshwant Kurhe, Mahesh Radhakrishnan & Deepali Gupta

Authors
  1. Yeshwant Kurhe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahesh Radhakrishnan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Deepali Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yeshwant Kurhe.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kurhe, Y., Radhakrishnan, M. & Gupta, D. Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests. Metab Brain Dis 29, 701–710 (2014). https://doi.org/10.1007/s11011-014-9574-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-014-9574-8

Keywords

Search

Navigation